Skip to content

Registry of Arterial Hypertension

Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04160533
Enrollment
10400
Registered
2019-11-13
Start date
2018-06-01
Completion date
2026-12-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension

Brief summary

The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population. The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations. The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice. Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.

Detailed description

The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension

Interventions

None listed

Sponsors

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

The diagnosis of arterial hypertension -

Exclusion criteria

No diagnosis of arterial hypertension \-

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with blood pressure <140/90 mm Hg2018 - 2021 yearsThe level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.

Secondary

MeasureTime frameDescription
Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.2018-2021Diagnosis data is entered by doctors as a "yes" or "no" category.
Antihypertensive medications2018-2021Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages

Countries

Russia

Contacts

CONTACTAnna Aksenova, MD
aksenovaannav@gmail.com+74954146186

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026